In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Watson buys Uteron for up to $305mm

Executive Summary

Watson Pharmaceuticals Inc. (changing its name to Actavis Inc.) has acquired closely held women’s health firm Uteron Pharma SA for $150mm in cash up front, plus up to $155mm in earn-outs (with $45mm in near-term milestones).
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Medical Devices
    • Implantable Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Includes Contract
    • Acquisition of Private Biotech
    • Payment Includes Cash
    • Full Acquisition

Related Companies

UsernamePublicRestriction

Register